6 Related NICE guidance

6 Related NICE guidance

Details are correct at the time of publication. Further information is available on the NICE website.

Under development

NICE is developing the following guidance (details available from www.nice.org.uk):

  • Dimethyl fumarate for treating relapsing–remitting multiple sclerosis. NICE technology appraisal. Publication expected January 2014.

  • Alemtuzumab for treating relapsing–remitting multiple sclerosis. NICE technology appraisal. Publication expected April 2014.

  • Laquinimod for treating relapsing–remitting multiple sclerosis. NICE technology appraisal. Publication expected February 2014.

  • National Institute for Health and Care Excellence (NICE)